These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3300294)

  • 1. The effect of ethanol on serum cyclosporine A levels in renal transplant recipients.
    Paul MD; Parfrey PS; Smart M; Gault H
    Am J Kidney Dis; 1987 Aug; 10(2):133-5. PubMed ID: 3300294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.
    Hegazy SK; Adam AG; Hamdy NA; Khalafallah NM
    Transpl Infect Dis; 2015 Jun; 17(3):350-60. PubMed ID: 25702620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection.
    Lefkowitz M; Jorkasky D; Kornbluth J
    Hum Immunol; 1987 Jun; 19(2):139-49. PubMed ID: 3301757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.
    Lindholm A; Henricsson S
    Ther Drug Monit; 1989 Nov; 11(6):623-30. PubMed ID: 2595741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of immunosuppression by serum inhibition of alloreaction and measurement of cyclosporin A (CyA) serum levels in kidney graft recipients under CyA.
    Chabannes D; Vernillet L; Cantarovich D; Humbert H; Vie H; Soulillou JP
    Transpl Int; 1990 Dec; 3(4):189-94. PubMed ID: 2076168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.
    Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of gout in renal transplant recipients.
    West C; Carpenter BJ; Hakala TR
    Am J Kidney Dis; 1987 Nov; 10(5):369-72. PubMed ID: 3314490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A enhances platelet aggregation.
    Grace AA; Barradas MA; Mikhailidis DP; Jeremy JY; Moorhead JF; Sweny P; Dandona P
    Kidney Int; 1987 Dec; 32(6):889-95. PubMed ID: 3323604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect.
    Stahl RA; Kanz L; Maier B; Schollmeyer P
    Clin Nephrol; 1986 May; 25(5):245-8. PubMed ID: 3521998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients.
    Pei Y; Richardson R; Greenwood C; Wong PY; Baines A
    Am J Kidney Dis; 1993 Aug; 22(2):314-9. PubMed ID: 8352259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyturia in cyclosporine-treated renal allograft recipients.
    Ashton A; Alexander DP; DeBellis C; Schumann GB
    Am J Clin Pathol; 1988 Jan; 89(1):113-7. PubMed ID: 3276140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total serum bile acids in renal transplanted patients receiving cyclosporine A.
    Tripodi V; Nuñez M; Carducci C; Mamianetti A; Agost Carreño C
    Clin Nephrol; 2002 Nov; 58(5):350-5. PubMed ID: 12425485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid-free treatment of renal transplant patients with cyclosporin A. A European multicentre study].
    Beveridge T; Maurer W; Poole TW; Wood AJ; Wiskott E
    Klin Wochenschr; 1982 Sep; 60(18):1137-42. PubMed ID: 6755046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
    Al-Awwa IA; Hariharan S; First MR
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S15-8. PubMed ID: 9631859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
    Qazi YA; Forrest A; Tornatore K; Venuto RC
    Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological analysis of glomerular lesions in renal transplants immunosuppressed with cyclosporine A (CYA): has CYA induced a new transplant glomerular lesion?
    Morozumi K; Yoshida A; Suganuma T; Satoh K; Aoki J; Oikawa T; Fujinami T; Uchida K; Yamada N; Orihara A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):282-5. PubMed ID: 2650121
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.